By Tom Salemi
Could a relatively low-tech approach to collecting stem cells from bone marrow aspirate help open the field of regenerative medicine?...
Harvest Steps into Stem Cells
Harvest Technologies, a 14-year-old player in the blood and marrow supply arena, is moving aggressively into the business of selling stem cells therapies for cardiovascular disease.